Early detection of Alzheimer's disease with PET imaging. Review uri icon

Overview

abstract

  • Preclinical diagnosis of Alzheimer's disease (AD) is one of the major challenges for the prevention of AD. AD biomarkers are needed not only to reveal preclinical pathologic changes, but also to monitor progression and therapeutics. PET neuroimaging can reliably assess aspects of the molecular biology and neuropathology of AD. The aim of this article is to review the use of FDG-PET and amyloid PET imaging in the early detection of AD.

publication date

  • March 3, 2010

Research

keywords

  • Alzheimer Disease
  • Positron-Emission Tomography

Identity

PubMed Central ID

  • PMC3214828

Scopus Document Identifier

  • 77449128266

Digital Object Identifier (DOI)

  • 10.1159/000289222

PubMed ID

  • 20197691

Additional Document Info

volume

  • 7

issue

  • 1-3